- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer ; volume:9 ; number:1 ; day:12 ; month:8 ; year:2016 ; pages:89-97 ; date:8.2016
BMC medical genomics ; 9, Heft 1 (12.8.2016), 89-97, 8.2016
- Creator
-
Bae, Min Gyun
- Contributor
-
Kim, Jeong Yeon
Choi, Jung Kyoon
SpringerLink (Online service)
- DOI
-
10.1186/s12920-016-0198-1
- URN
-
urn:nbn:de:1111-201609153429
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bae, Min Gyun
- Kim, Jeong Yeon
- Choi, Jung Kyoon
- SpringerLink (Online service)
Other Objects (12)
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa
CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
CpG island turnover events predict evolutionary changes in enhancer activity
A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
Orphan CpG islands dictate the compatibility between poised enhancers and their target genes
Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa
CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
CpG island turnover events predict evolutionary changes in enhancer activity
A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
Orphan CpG islands dictate the compatibility between poised enhancers and their target genes
Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa
CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
CpG island turnover events predict evolutionary changes in enhancer activity
A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
Orphan CpG islands dictate the compatibility between poised enhancers and their target genes